Application 063265
- Type
- ANDA
- Sponsor
- ABBOTT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMIKACIN SULFATE | AMIKACIN SULFATE | INJECTABLE;INJECTION | EQ 250MG BASE/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A063265-001 | AMIKACIN SULFATE | AMIKACIN SULFATE | EQ 250MG BASE/ML | INJECTABLE / INJECTION | 1994-11-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A063265-001 | AMIKACIN SULFATE | EQ 250MG BASE/ML | INJECTABLE / INJECTION | 1994-11-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A063265-001 | AMIKACIN SULFATE | EQ 250MG BASE/ML | INJECTABLE / INJECTION | 1994-11-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A063265-001 | AMIKACIN SULFATE | EQ 250MG BASE/ML | INJECTABLE / INJECTION | 1994-11-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A063265-001 | AMIKACIN SULFATE | EQ 250MG BASE/ML | INJECTABLE / INJECTION | 1994-11-30 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| amikacin sulfate | AMIKACIN SULFATE | Sagent Pharmaceuticals | f260ff2a-76a0-4672-9516-91c344b67890 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | amikacin sulfate AMIKACIN SULFATE |
| Amikacin Sulfate | AMIKACIN SULFATE | Mullan Pharmaceutical Inc. | 840ba25a-d60c-4f0d-a084-71b0c68237df | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | Amikacin Sulfate AMIKACIN SULFATE |
| Amikacin Sulfate | AMIKACIN SULFATE | Qilu Pharmaceutical Co., Ltd. | 20fa61ef-11e2-4d01-82ea-b5412cefaead | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | Amikacin Sulfate AMIKACIN SULFATE |
| Amikacin Sulfate | AMIKACIN SULFATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | a43188fa-f228-4acd-8a5d-9a3462034f4b | 2025-06-18 | Boxed warning, Warnings, Adverse reactions | Amikacin Sulfate AMIKACIN SULFATE |
| Amikacin Sulfate | AMIKACIN SULFATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7791d3e1-9287-4f75-b4f0-e5d35cacfd6e | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | Amikacin Sulfate AMIKACIN SULFATE |
| Amikacin Sulfate | AMIKACIN SULFATE | Hikma Pharmaceuticals USA Inc. | 0b56f6df-a05d-4520-8bf0-d7cefe20f6ad | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | Amikacin Sulfate AMIKACIN SULFATE |
| Amikacin Sulfate | AMIKACIN SULFATE | Fresenius Kabi USA, LLC | c0f57839-1c9b-49e5-8c7a-708e2d16495d | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | Amikacin Sulfate AMIKACIN SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.